Maund I F, Benson R J, Fairfoul J, Cook J, Huddart R, Poynter A
1 Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Br J Radiol. 2014 Dec;87(1044):20140459. doi: 10.1259/bjr.20140459. Epub 2014 Oct 29.
To investigate whether planning target volume (PTV) margins may be safely reduced in radiotherapy of localized prostate cancer incorporating daily online tube potential-cone beam CT (CBCT) image guidance and the anticipated benefit in predicted rectal toxicity.
The prostate-only clinical target volume (CTV2) and rectum were delineated on 1 pre-treatment CBCT each week in 18 randomly selected patients. By transposing these contours onto the original plan, dose-volume histograms (DVHs) for CTV2 and the rectum were each calculated and combined, for each patient, to produce a single mean DVH representative of the dose delivered over the treatment course. Plans were reoptimized using reduced CTV2 to PTV2 margins and the consequent radiobiological impact modelled by the tumour control probability (TCP) and normal tissue complication probability (NTCP) of the rectum.
All CBCT images were deemed of sufficient quality to identify the CTV and rectum. No loss of TCP was observed when plans using the standard 5-mm CTV2 to PTV2 margin of the centre were reoptimized with a 4- or 3-mm margin. Margin reduction was associated with a significant decrease in rectal NTCP (5-4 mm; p < 0.05 and 5-3 mm; p < 0.01).
Using daily online image guidance with CBCT, a reduction in CTV2 to PTV2 margins to 3 mm is achievable without compromising tumour control. The consequent sparing of surrounding normal tissues is associated with reduced anticipated rectal toxicity.
Margin reduction is feasible and potentially beneficial. Centres with image-guided radiotherapy capability should consider assessing whether margin reduction is possible within their institutes.
探讨在局部前列腺癌放射治疗中,结合每日在线管电压-锥形束CT(CBCT)图像引导技术,计划靶区(PTV)边界是否可以安全缩小,以及预测对直肠毒性的预期益处。
每周在18例随机选择的患者的1次治疗前CBCT上勾勒仅前列腺的临床靶区(CTV2)和直肠。通过将这些轮廓转移到原始计划上,分别计算每位患者CTV2和直肠的剂量体积直方图(DVH),并合并以生成代表整个治疗过程中所给予剂量的单个平均DVH。使用缩小的CTV2至PTV2边界重新优化计划,并通过直肠的肿瘤控制概率(TCP)和正常组织并发症概率(NTCP)对由此产生的放射生物学影响进行建模。
所有CBCT图像均被认为质量足以识别CTV和直肠。当使用中心标准的5 mm CTV2至PTV2边界的计划以4 mm或3 mm边界重新优化时,未观察到TCP损失。边界缩小与直肠NTCP显著降低相关(5至4 mm;p < 0.05和5至3 mm;p < 0.01)。
使用CBCT每日在线图像引导技术,可将CTV2至PTV2边界缩小至3 mm而不影响肿瘤控制。随之对周围正常组织的 sparing与预期直肠毒性降低相关。
边界缩小是可行的且可能有益。具备图像引导放射治疗能力的中心应考虑评估其机构内是否可能缩小边界。